Litigation

Recent Posts

Supreme Court: Generic Drug Makers Not Liable For Warnings
Posted on 24 Jun 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) The Supreme Court on Thursday ruled that makers of generic drugs cannot be sued for failing to warn consumers of the possible side effects of their products if they copy the exact warnings on the brand-name equivalents of the medicines... Read More

Teva Announces Trial Date In Generic Copaxone Litigation
Posted on 8 Mar 2011 by LexisNexis Litigation Resource Community Staff

JERUSALEM - Teva Pharmaceutical Industries Ltd. has announced that the U.S. District Court for the Southern District of New York has set a trial date of Sept. 7, 2011 in the company's ongoing patent infringement litigation against Momenta Pharmaceuticals... Read More

$500 Million In Punitive Damages Awarded Against Teva, Baxter In Propofol Infection Case
Posted on 10 May 2010 by Tom Moylan

LAS VEGAS — (Mealey’s) A Nevada state court jury on May 7 awarded $500 million in punitive damages in a propofol/hepatitis C infection case, two days after it awarded $5.35 million in compensatory damages, according to the parties ( Henry... Read More

Nevada Jury Awards $104 Million In Compensatory, Punitive Damages In Propofol Case
Posted on 13 Oct 2011 by Tom Moylan

LAS VEGAS - (Mealey's) A Nevada state court jury on Oct. 12 ordered a maker and distributor of generic propofol to pay $90 million in punitive damages in a case in which a plaintiff claimed that he was infected as a result of reusable "jumbo"... Read More